Request for Covid-19 Impact Assessment of this Report
The United States Irbesartan market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Irbesartan market, reaching US$ million by the year 2028. As for the Europe Irbesartan landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Irbesartan players cover Teva, Sanofi, BMS, and Sumitomo Dainippon Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Irbesartan market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Combination Drugs
Prescribed Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hyperlipidemia
High Blood Pressure
Heart Failure
Kidney Disease
Fibrous Fibrillation
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Teva
Sanofi
BMS
Sumitomo Dainippon Pharma
Novartis
Shionogi
Hanall
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Verdant Life Sciences
Angita Pharma
Auro Pharma
Avanstra
Zhuhai Rundu Pharma
Xiansheng Pharmaceutical
CTTQ
Tianjin Huairen Pharmaceutical
Jiangsu Wangao Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Ainuo Pharmaceutical
Yuanhe Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irbesartan Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Irbesartan by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Irbesartan by Country/Region, 2017, 2022 & 2028
2.2 Irbesartan Segment by Type
2.2.1 Combination Drugs
2.2.2 Prescribed Drugs
2.3 Irbesartan Sales by Type
2.3.1 Global Irbesartan Sales Market Share by Type (2017-2022)
2.3.2 Global Irbesartan Revenue and Market Share by Type (2017-2022)
2.3.3 Global Irbesartan Sale Price by Type (2017-2022)
2.4 Irbesartan Segment by Application
2.4.1 Hyperlipidemia
2.4.2 High Blood Pressure
2.4.3 Heart Failure
2.4.4 Kidney Disease
2.4.5 Fibrous Fibrillation
2.4.6 Other
2.5 Irbesartan Sales by Application
2.5.1 Global Irbesartan Sale Market Share by Application (2017-2022)
2.5.2 Global Irbesartan Revenue and Market Share by Application (2017-2022)
2.5.3 Global Irbesartan Sale Price by Application (2017-2022)
3 Global Irbesartan by Company
3.1 Global Irbesartan Breakdown Data by Company
3.1.1 Global Irbesartan Annual Sales by Company (2020-2022)
3.1.2 Global Irbesartan Sales Market Share by Company (2020-2022)
3.2 Global Irbesartan Annual Revenue by Company (2020-2022)
3.2.1 Global Irbesartan Revenue by Company (2020-2022)
3.2.2 Global Irbesartan Revenue Market Share by Company (2020-2022)
3.3 Global Irbesartan Sale Price by Company
3.4 Key Manufacturers Irbesartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Irbesartan Product Location Distribution
3.4.2 Players Irbesartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Irbesartan by Geographic Region
4.1 World Historic Irbesartan Market Size by Geographic Region (2017-2022)
4.1.1 Global Irbesartan Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Irbesartan Annual Revenue by Geographic Region
4.2 World Historic Irbesartan Market Size by Country/Region (2017-2022)
4.2.1 Global Irbesartan Annual Sales by Country/Region (2017-2022)
4.2.2 Global Irbesartan Annual Revenue by Country/Region
4.3 Americas Irbesartan Sales Growth
4.4 APAC Irbesartan Sales Growth
4.5 Europe Irbesartan Sales Growth
4.6 Middle East & Africa Irbesartan Sales Growth
5 Americas
5.1 Americas Irbesartan Sales by Country
5.1.1 Americas Irbesartan Sales by Country (2017-2022)
5.1.2 Americas Irbesartan Revenue by Country (2017-2022)
5.2 Americas Irbesartan Sales by Type
5.3 Americas Irbesartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irbesartan Sales by Region
6.1.1 APAC Irbesartan Sales by Region (2017-2022)
6.1.2 APAC Irbesartan Revenue by Region (2017-2022)
6.2 APAC Irbesartan Sales by Type
6.3 APAC Irbesartan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Irbesartan by Country
7.1.1 Europe Irbesartan Sales by Country (2017-2022)
7.1.2 Europe Irbesartan Revenue by Country (2017-2022)
7.2 Europe Irbesartan Sales by Type
7.3 Europe Irbesartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Irbesartan by Country
8.1.1 Middle East & Africa Irbesartan Sales by Country (2017-2022)
8.1.2 Middle East & Africa Irbesartan Revenue by Country (2017-2022)
8.2 Middle East & Africa Irbesartan Sales by Type
8.3 Middle East & Africa Irbesartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Irbesartan
10.3 Manufacturing Process Analysis of Irbesartan
10.4 Industry Chain Structure of Irbesartan
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Irbesartan Distributors
11.3 Irbesartan Customer
12 World Forecast Review for Irbesartan by Geographic Region
12.1 Global Irbesartan Market Size Forecast by Region
12.1.1 Global Irbesartan Forecast by Region (2023-2028)
12.1.2 Global Irbesartan Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Irbesartan Forecast by Type
12.7 Global Irbesartan Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Irbesartan Product Offered
13.1.3 Teva Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Irbesartan Product Offered
13.2.3 Sanofi Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 BMS
13.3.1 BMS Company Information
13.3.2 BMS Irbesartan Product Offered
13.3.3 BMS Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BMS Main Business Overview
13.3.5 BMS Latest Developments
13.4 Sumitomo Dainippon Pharma
13.4.1 Sumitomo Dainippon Pharma Company Information
13.4.2 Sumitomo Dainippon Pharma Irbesartan Product Offered
13.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sumitomo Dainippon Pharma Main Business Overview
13.4.5 Sumitomo Dainippon Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Irbesartan Product Offered
13.5.3 Novartis Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Shionogi
13.6.1 Shionogi Company Information
13.6.2 Shionogi Irbesartan Product Offered
13.6.3 Shionogi Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shionogi Main Business Overview
13.6.5 Shionogi Latest Developments
13.7 Hanall
13.7.1 Hanall Company Information
13.7.2 Hanall Irbesartan Product Offered
13.7.3 Hanall Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hanall Main Business Overview
13.7.5 Hanall Latest Developments
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Information
13.8.2 Taj Pharmaceuticals Irbesartan Product Offered
13.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Taj Pharmaceuticals Main Business Overview
13.8.5 Taj Pharmaceuticals Latest Developments
13.9 Apotex
13.9.1 Apotex Company Information
13.9.2 Apotex Irbesartan Product Offered
13.9.3 Apotex Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Apotex Main Business Overview
13.9.5 Apotex Latest Developments
13.10 Jiangsu Hengrui Medicine
13.10.1 Jiangsu Hengrui Medicine Company Information
13.10.2 Jiangsu Hengrui Medicine Irbesartan Product Offered
13.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jiangsu Hengrui Medicine Main Business Overview
13.10.5 Jiangsu Hengrui Medicine Latest Developments
13.11 Verdant Life Sciences
13.11.1 Verdant Life Sciences Company Information
13.11.2 Verdant Life Sciences Irbesartan Product Offered
13.11.3 Verdant Life Sciences Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Verdant Life Sciences Main Business Overview
13.11.5 Verdant Life Sciences Latest Developments
13.12 Angita Pharma
13.12.1 Angita Pharma Company Information
13.12.2 Angita Pharma Irbesartan Product Offered
13.12.3 Angita Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Angita Pharma Main Business Overview
13.12.5 Angita Pharma Latest Developments
13.13 Auro Pharma
13.13.1 Auro Pharma Company Information
13.13.2 Auro Pharma Irbesartan Product Offered
13.13.3 Auro Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Auro Pharma Main Business Overview
13.13.5 Auro Pharma Latest Developments
13.14 Avanstra
13.14.1 Avanstra Company Information
13.14.2 Avanstra Irbesartan Product Offered
13.14.3 Avanstra Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Avanstra Main Business Overview
13.14.5 Avanstra Latest Developments
13.15 Zhuhai Rundu Pharma
13.15.1 Zhuhai Rundu Pharma Company Information
13.15.2 Zhuhai Rundu Pharma Irbesartan Product Offered
13.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Zhuhai Rundu Pharma Main Business Overview
13.15.5 Zhuhai Rundu Pharma Latest Developments
13.16 Xiansheng Pharmaceutical
13.16.1 Xiansheng Pharmaceutical Company Information
13.16.2 Xiansheng Pharmaceutical Irbesartan Product Offered
13.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Xiansheng Pharmaceutical Main Business Overview
13.16.5 Xiansheng Pharmaceutical Latest Developments
13.17 CTTQ
13.17.1 CTTQ Company Information
13.17.2 CTTQ Irbesartan Product Offered
13.17.3 CTTQ Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 CTTQ Main Business Overview
13.17.5 CTTQ Latest Developments
13.18 Tianjin Huairen Pharmaceutical
13.18.1 Tianjin Huairen Pharmaceutical Company Information
13.18.2 Tianjin Huairen Pharmaceutical Irbesartan Product Offered
13.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Tianjin Huairen Pharmaceutical Main Business Overview
13.18.5 Tianjin Huairen Pharmaceutical Latest Developments
13.19 Jiangsu Wangao Pharmaceutical
13.19.1 Jiangsu Wangao Pharmaceutical Company Information
13.19.2 Jiangsu Wangao Pharmaceutical Irbesartan Product Offered
13.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Jiangsu Wangao Pharmaceutical Main Business Overview
13.19.5 Jiangsu Wangao Pharmaceutical Latest Developments
13.20 Zhejiang Huahai Pharmaceutical
13.20.1 Zhejiang Huahai Pharmaceutical Company Information
13.20.2 Zhejiang Huahai Pharmaceutical Irbesartan Product Offered
13.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.20.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.21 Zhejiang Ainuo Pharmaceutical
13.21.1 Zhejiang Ainuo Pharmaceutical Company Information
13.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Product Offered
13.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Zhejiang Ainuo Pharmaceutical Main Business Overview
13.21.5 Zhejiang Ainuo Pharmaceutical Latest Developments
13.22 Yuanhe Pharmaceutical
13.22.1 Yuanhe Pharmaceutical Company Information
13.22.2 Yuanhe Pharmaceutical Irbesartan Product Offered
13.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Yuanhe Pharmaceutical Main Business Overview
13.22.5 Yuanhe Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Irbesartan Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Irbesartan Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Combination Drugs
Table 4. Major Players of Prescribed Drugs
Table 5. Global Irbesartan Sales by Type (2017-2022) & (KG)
Table 6. Global Irbesartan Sales Market Share by Type (2017-2022)
Table 7. Global Irbesartan Revenue by Type (2017-2022) & ($ million)
Table 8. Global Irbesartan Revenue Market Share by Type (2017-2022)
Table 9. Global Irbesartan Sale Price by Type (2017-2022) & (US$/G)
Table 10. Global Irbesartan Sales by Application (2017-2022) & (KG)
Table 11. Global Irbesartan Sales Market Share by Application (2017-2022)
Table 12. Global Irbesartan Revenue by Application (2017-2022)
Table 13. Global Irbesartan Revenue Market Share by Application (2017-2022)
Table 14. Global Irbesartan Sale Price by Application (2017-2022) & (US$/G)
Table 15. Global Irbesartan Sales by Company (2020-2022) & (KG)
Table 16. Global Irbesartan Sales Market Share by Company (2020-2022)
Table 17. Global Irbesartan Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Irbesartan Revenue Market Share by Company (2020-2022)
Table 19. Global Irbesartan Sale Price by Company (2020-2022) & (US$/G)
Table 20. Key Manufacturers Irbesartan Producing Area Distribution and Sales Area
Table 21. Players Irbesartan Products Offered
Table 22. Irbesartan Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Irbesartan Sales by Geographic Region (2017-2022) & (KG)
Table 26. Global Irbesartan Sales Market Share Geographic Region (2017-2022)
Table 27. Global Irbesartan Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Irbesartan Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Irbesartan Sales by Country/Region (2017-2022) & (KG)
Table 30. Global Irbesartan Sales Market Share by Country/Region (2017-2022)
Table 31. Global Irbesartan Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Irbesartan Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Irbesartan Sales by Country (2017-2022) & (KG)
Table 34. Americas Irbesartan Sales Market Share by Country (2017-2022)
Table 35. Americas Irbesartan Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Irbesartan Revenue Market Share by Country (2017-2022)
Table 37. Americas Irbesartan Sales by Type (2017-2022) & (KG)
Table 38. Americas Irbesartan Sales Market Share by Type (2017-2022)
Table 39. Americas Irbesartan Sales by Application (2017-2022) & (KG)
Table 40. Americas Irbesartan Sales Market Share by Application (2017-2022)
Table 41. APAC Irbesartan Sales by Region (2017-2022) & (KG)
Table 42. APAC Irbesartan Sales Market Share by Region (2017-2022)
Table 43. APAC Irbesartan Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Irbesartan Revenue Market Share by Region (2017-2022)
Table 45. APAC Irbesartan Sales by Type (2017-2022) & (KG)
Table 46. APAC Irbesartan Sales Market Share by Type (2017-2022)
Table 47. APAC Irbesartan Sales by Application (2017-2022) & (KG)
Table 48. APAC Irbesartan Sales Market Share by Application (2017-2022)
Table 49. Europe Irbesartan Sales by Country (2017-2022) & (KG)
Table 50. Europe Irbesartan Sales Market Share by Country (2017-2022)
Table 51. Europe Irbesartan Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Irbesartan Revenue Market Share by Country (2017-2022)
Table 53. Europe Irbesartan Sales by Type (2017-2022) & (KG)
Table 54. Europe Irbesartan Sales Market Share by Type (2017-2022)
Table 55. Europe Irbesartan Sales by Application (2017-2022) & (KG)
Table 56. Europe Irbesartan Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Irbesartan Sales by Country (2017-2022) & (KG)
Table 58. Middle East & Africa Irbesartan Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Irbesartan Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Irbesartan Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Irbesartan Sales by Type (2017-2022) & (KG)
Table 62. Middle East & Africa Irbesartan Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Irbesartan Sales by Application (2017-2022) & (KG)
Table 64. Middle East & Africa Irbesartan Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Irbesartan
Table 66. Key Market Challenges & Risks of Irbesartan
Table 67. Key Industry Trends of Irbesartan
Table 68. Irbesartan Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Irbesartan Distributors List
Table 71. Irbesartan Customer List
Table 72. Global Irbesartan Sales Forecast by Region (2023-2028) & (KG)
Table 73. Global Irbesartan Sales Market Forecast by Region
Table 74. Global Irbesartan Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Irbesartan Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Irbesartan Sales Forecast by Country (2023-2028) & (KG)
Table 77. Americas Irbesartan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Irbesartan Sales Forecast by Region (2023-2028) & (KG)
Table 79. APAC Irbesartan Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Irbesartan Sales Forecast by Country (2023-2028) & (KG)
Table 81. Europe Irbesartan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Irbesartan Sales Forecast by Country (2023-2028) & (KG)
Table 83. Middle East & Africa Irbesartan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Irbesartan Sales Forecast by Type (2023-2028) & (KG)
Table 85. Global Irbesartan Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Irbesartan Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Irbesartan Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Irbesartan Sales Forecast by Application (2023-2028) & (KG)
Table 89. Global Irbesartan Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Irbesartan Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Irbesartan Revenue Market Share Forecast by Application (2023-2028)
Table 92. Teva Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Irbesartan Product Offered
Table 94. Teva Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 95. Teva Main Business
Table 96. Teva Latest Developments
Table 97. Sanofi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Irbesartan Product Offered
Table 99. Sanofi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 100. Sanofi Main Business
Table 101. Sanofi Latest Developments
Table 102. BMS Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 103. BMS Irbesartan Product Offered
Table 104. BMS Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 105. BMS Main Business
Table 106. BMS Latest Developments
Table 107. Sumitomo Dainippon Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 108. Sumitomo Dainippon Pharma Irbesartan Product Offered
Table 109. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 110. Sumitomo Dainippon Pharma Main Business
Table 111. Sumitomo Dainippon Pharma Latest Developments
Table 112. Novartis Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 113. Novartis Irbesartan Product Offered
Table 114. Novartis Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 115. Novartis Main Business
Table 116. Novartis Latest Developments
Table 117. Shionogi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 118. Shionogi Irbesartan Product Offered
Table 119. Shionogi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 120. Shionogi Main Business
Table 121. Shionogi Latest Developments
Table 122. Hanall Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 123. Hanall Irbesartan Product Offered
Table 124. Hanall Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 125. Hanall Main Business
Table 126. Hanall Latest Developments
Table 127. Taj Pharmaceuticals Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 128. Taj Pharmaceuticals Irbesartan Product Offered
Table 129. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 130. Taj Pharmaceuticals Main Business
Table 131. Taj Pharmaceuticals Latest Developments
Table 132. Apotex Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 133. Apotex Irbesartan Product Offered
Table 134. Apotex Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 135. Apotex Main Business
Table 136. Apotex Latest Developments
Table 137. Jiangsu Hengrui Medicine Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Hengrui Medicine Irbesartan Product Offered
Table 139. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 140. Jiangsu Hengrui Medicine Main Business
Table 141. Jiangsu Hengrui Medicine Latest Developments
Table 142. Verdant Life Sciences Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 143. Verdant Life Sciences Irbesartan Product Offered
Table 144. Verdant Life Sciences Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 145. Verdant Life Sciences Main Business
Table 146. Verdant Life Sciences Latest Developments
Table 147. Angita Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 148. Angita Pharma Irbesartan Product Offered
Table 149. Angita Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 150. Angita Pharma Main Business
Table 151. Angita Pharma Latest Developments
Table 152. Auro Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 153. Auro Pharma Irbesartan Product Offered
Table 154. Auro Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 155. Auro Pharma Main Business
Table 156. Auro Pharma Latest Developments
Table 157. Avanstra Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 158. Avanstra Irbesartan Product Offered
Table 159. Avanstra Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 160. Avanstra Main Business
Table 161. Avanstra Latest Developments
Table 162. Zhuhai Rundu Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 163. Zhuhai Rundu Pharma Irbesartan Product Offered
Table 164. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 165. Zhuhai Rundu Pharma Main Business
Table 166. Zhuhai Rundu Pharma Latest Developments
Table 167. Xiansheng Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 168. Xiansheng Pharmaceutical Irbesartan Product Offered
Table 169. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 170. Xiansheng Pharmaceutical Main Business
Table 171. Xiansheng Pharmaceutical Latest Developments
Table 172. CTTQ Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 173. CTTQ Irbesartan Product Offered
Table 174. CTTQ Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 175. CTTQ Main Business
Table 176. CTTQ Latest Developments
Table 177. Tianjin Huairen Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 178. Tianjin Huairen Pharmaceutical Irbesartan Product Offered
Table 179. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 180. Tianjin Huairen Pharmaceutical Main Business
Table 181. Tianjin Huairen Pharmaceutical Latest Developments
Table 182. Jiangsu Wangao Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 183. Jiangsu Wangao Pharmaceutical Irbesartan Product Offered
Table 184. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 185. Jiangsu Wangao Pharmaceutical Main Business
Table 186. Jiangsu Wangao Pharmaceutical Latest Developments
Table 187. Zhejiang Huahai Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 188. Zhejiang Huahai Pharmaceutical Irbesartan Product Offered
Table 189. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 190. Zhejiang Huahai Pharmaceutical Main Business
Table 191. Zhejiang Huahai Pharmaceutical Latest Developments
Table 192. Zhejiang Ainuo Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 193. Zhejiang Ainuo Pharmaceutical Irbesartan Product Offered
Table 194. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 195. Zhejiang Ainuo Pharmaceutical Main Business
Table 196. Zhejiang Ainuo Pharmaceutical Latest Developments
Table 197. Yuanhe Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 198. Yuanhe Pharmaceutical Irbesartan Product Offered
Table 199. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 200. Yuanhe Pharmaceutical Main Business
Table 201. Yuanhe Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Irbesartan
Figure 2. Irbesartan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Irbesartan Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Irbesartan Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Irbesartan Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Combination Drugs
Figure 10. Product Picture of Prescribed Drugs
Figure 11. Global Irbesartan Sales Market Share by Type in 2021
Figure 12. Global Irbesartan Revenue Market Share by Type (2017-2022)
Figure 13. Irbesartan Consumed in Hyperlipidemia
Figure 14. Global Irbesartan Market: Hyperlipidemia (2017-2022) & (KG)
Figure 15. Irbesartan Consumed in High Blood Pressure
Figure 16. Global Irbesartan Market: High Blood Pressure (2017-2022) & (KG)
Figure 17. Irbesartan Consumed in Heart Failure
Figure 18. Global Irbesartan Market: Heart Failure (2017-2022) & (KG)
Figure 19. Irbesartan Consumed in Kidney Disease
Figure 20. Global Irbesartan Market: Kidney Disease (2017-2022) & (KG)
Figure 21. Irbesartan Consumed in Fibrous Fibrillation
Figure 22. Global Irbesartan Market: Fibrous Fibrillation (2017-2022) & (KG)
Figure 23. Irbesartan Consumed in Other
Figure 24. Global Irbesartan Market: Other (2017-2022) & (KG)
Figure 25. Global Irbesartan Sales Market Share by Application (2017-2022)
Figure 26. Global Irbesartan Revenue Market Share by Application in 2021
Figure 27. Irbesartan Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Irbesartan Revenue Market Share by Company in 2021
Figure 29. Global Irbesartan Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Irbesartan Revenue Market Share by Geographic Region in 2021
Figure 31. Global Irbesartan Sales Market Share by Region (2017-2022)
Figure 32. Global Irbesartan Revenue Market Share by Country/Region in 2021
Figure 33. Americas Irbesartan Sales 2017-2022 (KG)
Figure 34. Americas Irbesartan Revenue 2017-2022 ($ Millions)
Figure 35. APAC Irbesartan Sales 2017-2022 (KG)
Figure 36. APAC Irbesartan Revenue 2017-2022 ($ Millions)
Figure 37. Europe Irbesartan Sales 2017-2022 (KG)
Figure 38. Europe Irbesartan Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Irbesartan Sales 2017-2022 (KG)
Figure 40. Middle East & Africa Irbesartan Revenue 2017-2022 ($ Millions)
Figure 41. Americas Irbesartan Sales Market Share by Country in 2021
Figure 42. Americas Irbesartan Revenue Market Share by Country in 2021
Figure 43. United States Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Irbesartan Sales Market Share by Region in 2021
Figure 48. APAC Irbesartan Revenue Market Share by Regions in 2021
Figure 49. China Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Irbesartan Sales Market Share by Country in 2021
Figure 56. Europe Irbesartan Revenue Market Share by Country in 2021
Figure 57. Germany Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Irbesartan Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Irbesartan Revenue Market Share by Country in 2021
Figure 64. Egypt Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Irbesartan Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Irbesartan in 2021
Figure 70. Manufacturing Process Analysis of Irbesartan
Figure 71. Industry Chain Structure of Irbesartan
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...